Clinical Trial Update: Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

View source ↗

Summary

A clinical trial is evaluating multiparametric MRI as a noninvasive method to assess response of HER2-positive breast cancer to anti-HER2 therapy; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer | Status: ACTIVE_NOT_RECRUITING